Mergen.financeOncosem Onkolojik Sistemler
| Year |
|---|
| Jan |
|---|
| Feb |
|---|
| Mar |
|---|
| Apr |
|---|
| May |
|---|
| Jun |
|---|
| Jul |
|---|
| Aug |
|---|
| Sept |
|---|
| Oct |
|---|
| Nov |
|---|
| Dec |
|---|
| Year |
|---|
| 2026 | ▲ 15.8% | ▼ 9.3% | ▼ 8.6% | ▲ 8.3% | ▲ 7.6% | ▼ 15.0% | ▲ 1.1% | ▼ 11.4% | ▼ 64.6% | ▲ 5.7% | ▲ 5.5% | ▼ 66.3% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ▲ 15.9% |
From our own closes, each month-end against the previous month-end. Colour saturates at ▲ 15.9%; an empty cell means no data, a dash means we declined to derive one.
Fiscal period: FY · 2025-12-31 · Konsolide — annual data, not TTM · TRY · Source: KAP
Balance-sheet lines and ratios (assets, equity, ROE, ROA, net margin, debt/equity) open on the paid plans. See the plans